Elimination of 4-n-butoxyphenylacethydroxamic acid (bufexamac) in man.
D000284:Administration, Oral; D000893:Anti-Inflammatory Agents / Q000652:urine*; D002986:Clinical Trials as Topic; D004987:Ethers / Q000008:administration & dosage / Q000652:urine; D005966:Glucuronidase; D006801:Humans; D006863:Hydrogen-Ion Concentration; D006868:Hydrolysis; D006877:Hydroxamic Acids / Q000008:administration & dosage / Q000652:urine*; D006898:Hydroxylamines; D008297:Male; D010648:Phenylacetates / Q000008:administration & dosage / Q000652:urine*; D013997:Time Factors
D000893:Anti-Inflammatory Agents; D004987:Ethers; D006877:Hydroxamic Acids; D006898:Hydroxylamines; D010648:Phenylacetates; D005966:Glucuronidase